Benchmark Initiates Coverage On Milestone Scientific with Speculative Buy Rating, Announces Price Target of $1.25
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson has initiated coverage on Milestone Scientific (AMEX:MLSS) with a Speculative Buy rating and set a price target of $1.25.
October 10, 2024 | 1:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark has initiated coverage on Milestone Scientific with a Speculative Buy rating and a price target of $1.25, indicating potential upside.
The initiation of coverage with a Speculative Buy rating and a price target of $1.25 by Benchmark suggests a positive outlook for Milestone Scientific. This could lead to increased investor interest and potential stock price appreciation in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100